These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9736924)

  • 1. Therapeutic potential of selective estrogen receptor modulators.
    Gustafsson JA
    Curr Opin Chem Biol; 1998 Aug; 2(4):508-11. PubMed ID: 9736924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical effects of raloxifene hydrochloride in women.
    Khovidhunkit W; Shoback DM
    Ann Intern Med; 1999 Mar; 130(5):431-9. PubMed ID: 10068418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women.
    Fitzpatrick LA
    Mayo Clin Proc; 1999 Jun; 74(6):601-7. PubMed ID: 10377937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
    Pickar JH; Komm BS
    Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raloxifene: magic bullet for heart and bone?
    Gustafsson JA
    Nat Med; 1998 Feb; 4(2):152-3. PubMed ID: 9461183
    [No Abstract]   [Full Text] [Related]  

  • 7. Raloxifene: a selective estrogen receptor modulator.
    Scott JA; Da Camara CC; Early JE
    Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene.
    Yang NN; Venugopalan M; Hardikar S; Glasebrook A
    Science; 1996 Aug; 273(5279):1222-5. PubMed ID: 8703055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An estrogen receptor basis for raloxifene action in bone.
    Bryant HU; Glasebrook AL; Yang NN; Sato M
    J Steroid Biochem Mol Biol; 1999; 69(1-6):37-44. PubMed ID: 10418979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective estrogen receptor modulators: a look ahead.
    Mitlak BH; Cohen FJ
    Drugs; 1999 May; 57(5):653-63. PubMed ID: 10353293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective estrogen receptor modulators (SERMs).
    Grese TA; Dodge JA
    Curr Pharm Des; 1998 Feb; 4(1):71-92. PubMed ID: 10197034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the molecular biology of the estrogen receptor define novel therapeutic targets for breast cancer.
    Hanstein B; Djahansouzi S; Dall P; Beckmann MW; Bender HG
    Eur J Endocrinol; 2004 Mar; 150(3):243-55. PubMed ID: 15012607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective estrogen receptor modulators and postmenopausal women's health.
    Hol T; Cox MB; Bryant HU; Draper MW
    J Womens Health; 1997 Oct; 6(5):523-31. PubMed ID: 9356975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective estrogen receptor modulators: a new category of therapeutic agents for extending the health of postmenopausal women.
    Goldstein SR
    Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1479-84. PubMed ID: 9855584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
    Franks AL; Steinberg KK
    JAMA; 1999 Jun; 281(23):2243-4. PubMed ID: 10376579
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
    Paech K; Webb P; Kuiper GG; Nilsson S; Gustafsson J; Kushner PJ; Scanlan TS
    Science; 1997 Sep; 277(5331):1508-10. PubMed ID: 9278514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulators: mechanism of action and clinical experience. Focus on raloxifene.
    Thiebaud D; Secrest RJ
    Reprod Fertil Dev; 2001; 13(4):331-6. PubMed ID: 11800172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular determinants of tissue selectivity in estrogen receptor modulators.
    Grese TA; Sluka JP; Bryant HU; Cullinan GJ; Glasebrook AL; Jones CD; Matsumoto K; Palkowitz AD; Sato M; Termine JD; Winter MA; Yang NN; Dodge JA
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):14105-10. PubMed ID: 9391160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide antagonists of the human estrogen receptor.
    Norris JD; Paige LA; Christensen DJ; Chang CY; Huacani MR; Fan D; Hamilton PT; Fowlkes DM; McDonnell DP
    Science; 1999 Jul; 285(5428):744-6. PubMed ID: 10426998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Raloxifene, a new selective estrogen receptor modulator.
    Goldfrank D; Haytoglu T; Frishman WH; Mohammad Z
    J Clin Pharmacol; 1999 Aug; 39(8):767-74. PubMed ID: 10434227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.